BSE Live
Jan 23, 16:01Prev. Close
4055.60
Open Price
4055.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:55Prev. Close
4055.30
Open Price
4055.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Sanofi India (in Rs. Cr.) | Dec 09 | Dec 08 | Dec 07 | Dec 06 | Dec 05 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 68.35 | 72.16 | 62.71 | 73.51 | 63.00 | |
| Diluted EPS (Rs.) | 68.35 | 72.16 | 62.71 | 73.51 | 63.00 | |
| Cash EPS (Rs.) | 75.88 | 80.07 | 70.72 | 81.26 | 70.46 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 398.67 | 353.72 | 300.28 | 257.08 | 220.06 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 404.59 | 360.00 | 306.92 | 264.09 | 227.43 | |
| Dividend / Share(Rs.) | 20.00 | 16.00 | 16.00 | 32.00 | 16.00 | |
| Revenue from Operations/Share (Rs.) | 446.04 | 447.81 | 386.46 | 387.20 | 354.20 | |
| PBDIT/Share (Rs.) | 108.52 | 119.54 | 102.69 | 116.25 | 109.95 | |
| PBIT/Share (Rs.) | 100.99 | 111.63 | 94.67 | 108.50 | 102.48 | |
| PBT/Share (Rs.) | 100.95 | 111.48 | 94.59 | 108.42 | 102.46 | |
| Net Profit/Share (Rs.) | 68.35 | 72.16 | 62.71 | 73.51 | 63.00 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 24.32 | 26.69 | 26.57 | 30.02 | 31.04 | |
| PBIT Margin (%) | 22.64 | 24.92 | 24.49 | 28.02 | 28.93 | |
| PBT Margin (%) | 22.63 | 24.89 | 24.47 | 28.00 | 28.92 | |
| Net Profit Margin (%) | 15.32 | 16.11 | 16.22 | 18.98 | 17.78 | |
| Return on Networth / Equity (%) | 17.14 | 20.40 | 20.88 | 28.59 | 28.62 | |
| Return on Capital Employed (%) | 16.62 | 19.73 | 20.03 | 27.20 | 26.89 | |
| Return on Assets (%) | 12.89 | 15.41 | 15.53 | 19.40 | 20.42 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 84.16 | 95.65 | 95.74 | 102.23 | 114.81 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.71 | 3.79 | 3.61 | 2.78 | 3.17 | |
| Quick Ratio (X) | 2.86 | 3.06 | 2.74 | 2.14 | 2.37 | |
| Inventory Turnover Ratio (X) | 4.44 | 5.98 | 4.92 | 5.62 | 5.98 | |
| Dividend Payout Ratio (NP) (%) | 29.26 | 22.17 | 25.51 | 43.53 | 25.39 | |
| Dividend Payout Ratio (CP) (%) | 26.35 | 19.98 | 22.62 | 39.38 | 22.70 | |
| Earnings Retention Ratio (%) | 70.74 | 77.83 | 74.49 | 56.47 | 74.61 | |
| Cash Earnings Retention Ratio (%) | 73.65 | 80.02 | 77.38 | 60.62 | 77.30 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3,318.20 | 1,698.13 | 2,288.07 | 2,726.70 | 3,518.79 | |
| EV/Net Operating Revenue (X) | 3.23 | 1.65 | 2.57 | 3.06 | 4.31 | |
| EV/EBITDA (X) | 13.28 | 6.17 | 9.67 | 10.18 | 13.90 | |
| MarketCap/Net Operating Revenue (X) | 3.80 | 2.13 | 3.01 | 3.49 | 4.67 | |
| Retention Ratios (%) | 70.73 | 77.82 | 74.48 | 56.46 | 74.60 | |
| Price/BV (X) | 4.25 | 2.70 | 3.87 | 5.26 | 7.52 | |
| Price/Net Operating Revenue | 3.80 | 2.13 | 3.01 | 3.49 | 4.67 | |
| Earnings Yield | 0.04 | 0.08 | 0.05 | 0.05 | 0.04 |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y